MedWatch

WS Audiology's revenue grows by 10 percent in Q1

In the first quarter of financial year 2021/2022, WSA has reached the highest organic growth of 10 percent since Widex and Sivantos merged to forge the company.

WS Audiology's headquarters in Copenhagen | Photo: WS Audiology / PR

On Thursday morning, hearing group WS Audiology has publicized its financial figures for the first quarter of the skewed accounting period 2021/2022.

WSA books a revenue of EUR 582m, corresponding to a 10-percent organic revenue growth in Q1 compared to Q1 2020/2021.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Related articles

Latest news

See all jobs